ROCK promotes hypoxia-induced cardiomyocyte apoptosis by inhibiting PI3K/Akt pathway

AIM: To investigate the expression of Rho-associated coiled-coil protein kinase (ROCK) at different hypoxic phases and to explore its role in myocardial cell apoptosis. METHODS: The rat cardiomyocytes were primarily cultured and identified by an antibody targeting α-actin of striated muscle. The myocardial cell hypoxic model was established by exposing the cells in hypoxic liquid for 1 h, 3 h, 6 h and 9 h. The cell apoptotic rate was assessed by flow cytometry. The cell survival rate was determined by MTT assay. The protein levels of ROCK-1, ROCK-2, caspase-3 activation fragment, PI3K and p-PI3K at different hypoxia phases were determined by Western blotting.RESULTS: After exposed to hypoxic liquid for 1 h, 3 h, 6 h and 9 h, the apoptotic rates of the cardiomyocytes were （8.76±1.51）%, （15.36±2.34）%, （26.50±3.43）% and （41.96±4.22）%, respectively, significantly higher than those in control group ［(2.60±0.34）%, P<0.01］. The survival rates were （93.20±4.12）%, （86.14±3.10）%, （75.53±7.25）%and （60.21±6.75）%, respectively, signficantly lower than those in control group ［（97.60±1.12）%, P<0.05］. After 1 h of hypoxic exposure, the levels of ROCK-1 and ROCK-2 began to rise, reached its peak at 3～6 h, and began to decrease after 9 h, which were significantly higher than those in control group (P<0.05). After 1 h of hypoxic exposure, the caspase-3 activation fragment began to rise, which was sustained in a high level at following observed time points as compared with control group (P<0.01). No difference of the PI3K expression in the course of hypoxia was observed. However, after 1 h of hypoxic exposure, the p-PI3K level began to rise, reached its peak at 3 h, began to decrease at 6 h, and was almost undetectable at 9 h. CONCLUSION: Hypoxia stimulates the cardiomyocytes to increase the expression of ROCK-1 and ROCK-2, and is in parallel with the cardiomyocyte apoptosis. ROCKs may play an important role in the process of hypoxia-induced cardiomyocyte apoptosis by inhibiting the p-PI3K pathways.